Biosynex SA
PAR:ALBIO

Watchlist Manager
Biosynex SA Logo
Biosynex SA
PAR:ALBIO
Watchlist
Price: 4.06 EUR -0.12% Market Closed
Updated: May 23, 2024

Intrinsic Value

Biosynex SA engages in the development, production, and distribution of Rapid Diagnostics Tests (RDTs) for pathologies. [ Read More ]

The intrinsic value of one ALBIO stock under the Base Case scenario is hidden EUR. Compared to the current market price of 4.06 EUR, Biosynex SA is hidden .

Key Points:
ALBIO Intrinsic Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Backtest
Biosynex SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ALBIO stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Biosynex SA

Provide an overview of the primary business activities
of Biosynex SA.

What unique competitive advantages
does Biosynex SA hold over its rivals?

What risks and challenges
does Biosynex SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biosynex SA.

Provide P/S
for Biosynex SA.

Provide P/E
for Biosynex SA.

Provide P/OCF
for Biosynex SA.

Provide P/FCFE
for Biosynex SA.

Provide P/B
for Biosynex SA.

Provide EV/S
for Biosynex SA.

Provide EV/GP
for Biosynex SA.

Provide EV/EBITDA
for Biosynex SA.

Provide EV/EBIT
for Biosynex SA.

Provide EV/OCF
for Biosynex SA.

Provide EV/FCFF
for Biosynex SA.

Provide EV/IC
for Biosynex SA.

Show me price targets
for Biosynex SA made by professional analysts.

What are the Revenue projections
for Biosynex SA?

How accurate were the past Revenue estimates
for Biosynex SA?

What are the Net Income projections
for Biosynex SA?

How accurate were the past Net Income estimates
for Biosynex SA?

What are the EPS projections
for Biosynex SA?

How accurate were the past EPS estimates
for Biosynex SA?

What are the EBIT projections
for Biosynex SA?

How accurate were the past EBIT estimates
for Biosynex SA?

Compare the revenue forecasts
for Biosynex SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biosynex SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biosynex SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biosynex SA compared to its peers.

Compare the P/E ratios
of Biosynex SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Biosynex SA with its peers.

Analyze the financial leverage
of Biosynex SA compared to its main competitors.

Show all profitability ratios
for Biosynex SA.

Provide ROE
for Biosynex SA.

Provide ROA
for Biosynex SA.

Provide ROIC
for Biosynex SA.

Provide ROCE
for Biosynex SA.

Provide Gross Margin
for Biosynex SA.

Provide Operating Margin
for Biosynex SA.

Provide Net Margin
for Biosynex SA.

Provide FCF Margin
for Biosynex SA.

Show all solvency ratios
for Biosynex SA.

Provide D/E Ratio
for Biosynex SA.

Provide D/A Ratio
for Biosynex SA.

Provide Interest Coverage Ratio
for Biosynex SA.

Provide Altman Z-Score Ratio
for Biosynex SA.

Provide Quick Ratio
for Biosynex SA.

Provide Current Ratio
for Biosynex SA.

Provide Cash Ratio
for Biosynex SA.

What is the historical Revenue growth
over the last 5 years for Biosynex SA?

What is the historical Net Income growth
over the last 5 years for Biosynex SA?

What is the current Free Cash Flow
of Biosynex SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biosynex SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biosynex SA

Current Assets 125.8m
Cash & Short-Term Investments 45.3m
Receivables 30.8m
Other Current Assets 49.7m
Non-Current Assets 146.4m
Long-Term Investments 2.6m
PP&E 17.3m
Intangibles 126.5m
Other Non-Current Assets -1k
Current Liabilities 107.6m
Accounts Payable 14.4m
Accrued Liabilities 11.9m
Short-Term Debt 198k
Other Current Liabilities 81m
Non-Current Liabilities 27.9m
Long-Term Debt 16.9m
Other Non-Current Liabilities 11m
Efficiency

Earnings Waterfall
Biosynex SA

Revenue
93.1m EUR
Operating Expenses
-101.9m EUR
Operating Income
-8.9m EUR
Other Expenses
-4.9m EUR
Net Income
-13.8m EUR

Free Cash Flow Analysis
Biosynex SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

ALBIO Profitability Score
Profitability Due Diligence

Biosynex SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional 3-Year Average ROE
Negative Operating Income
Negative Net Income
hidden
Profitability
Score

Biosynex SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ALBIO Solvency Score
Solvency Due Diligence

Biosynex SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Long-Term Solvency
Short-Term Solvency
hidden
Solvency
Score

Biosynex SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALBIO Price Targets Summary
Biosynex SA

Wall Street analysts forecast ALBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALBIO is 12.85 EUR with a low forecast of 12.73 EUR and a high forecast of 13.23 EUR.

Lowest
Price Target
12.73 EUR
213% Upside
Average
Price Target
12.85 EUR
217% Upside
Highest
Price Target
13.23 EUR
226% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
Biosynex SA

Shareholder Return

ALBIO Price
Biosynex SA

1M 1M
-23%
6M 6M
-51%
1Y 1Y
-55%
3Y 3Y
-82%
5Y 5Y
+66%
10Y 10Y
-27%
Annual Price Range
4.06
52w Low
4.025
52w High
10.92
Price Metrics
Average Annual Return 128.15%
Standard Deviation of Annual Returns 237.63%
Max Drawdown -84%
Shares Statistics
Market Capitalization 40.6m EUR
Shares Outstanding 10 760 900
Percentage of Shares Shorted
N/A

ALBIO Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Biosynex SA Logo
Biosynex SA

Country

France

Industry

Health Care

Market Cap

40.6m EUR

Dividend Yield

0%

Description

Biosynex SA engages in the development, production, and distribution of Rapid Diagnostics Tests (RDTs) for pathologies. The company is headquartered in Illkirch-Graffenstaden, Grand Est. The company went IPO on 2011-03-21. The Company’s products are used by biological and analytical services laboratories, obstetric units and emergency units, as well as in medical resource-limited settings. Biosynex SA specializes in four fields: tropical diseases, emergency markers, infectious diseases and autoimmunity. The Company’s products include Amnioquick (Obstetrics); Immunoquick Malaria Falciparum and Immunoquick Malaria +4 (Parasitology); Immunoquick Elifa HSV IGG, Immunoquick Elifa EBV G and Immunoquick Mono (Virology); Immunoquick Filtration CELIAC IgA and Immunoquick TG (Autoimmunology); and Immunoquick Tetanus (Bacteriology). The company operates through Fumouze Diagnostics and SR2B.

Contact

GRAND EST
Illkirch-Graffenstaden
22 Boulevard Sebastien Brant
+33388787887
https://www.biosynex.com

IPO

2011-03-21

Employees

328

Officers

Chairman & CEO
Mr. Larry Abensur
Deputy CEO & Director
Mr. Thomas Lamy

See Also

Discover More
What is the Intrinsic Value of one ALBIO stock?

The intrinsic value of one ALBIO stock under the Base Case scenario is hidden EUR.

Is ALBIO stock undervalued or overvalued?

Compared to the current market price of 4.06 EUR, Biosynex SA is hidden .